ARTICLE | Company News
Confluence Pharmaceuticals, AOP Orphan deal
April 27, 2015 7:00 AM UTC
Confluence and AOP partnered to co-develop and market Confluence’s preclinical compound based on a formulation of acamproate, for pediatric Fragile X syndrome in the EU and Middle East. Confluence wil...